Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Mounjaro (tirzepatide) EPAR Product Information
Key Takeaways on GLP-1 Medications for Athletes GLP-1 medications were designed for specific medical uses, not as a blanket solution Understanding why someone wants to use a GLP-1 and the risks involved matters Appetite suppression can make it difficult for active people to meet fueling needs Starting a GLP-1 while training for a race (especially an endurance event) increases risk Being leaner does not automatically improve performance The decision to take a GLP-1 medication (or not) requires careful consideration and individualized support This first episode on GLP-1 medications lays the groundwork for the rest of the series, and the next two conversations will build on this foundation in really important ways
June 2020: Ozempic Associated With Diabetic Retinopathy and Adverse Ocular Events A study found that Ozempic is associated with diabetic retinopathy and adverse ocular events more than some other GLP-1 receptor agonists
About this neurodevelopment and aging research news Author: Ben Schamisso Source: Northwestern University Contact: Ben Schamisso Northwestern University Image: The image is credited to Neuroscience News Original Research: The findings will be presented at ENDO 2026
US$ 23.84
US$ 28.77
US$ 20.61
US$ 27.52
US$ 23.99
US$ 25.91
